The dominant 97.5% market-implied probability on an 85–90 flu hospitalization rate for Week 21, 2026, reflects the expected stabilization of cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET as the 2025–2026 season concludes. Activity has declined sharply since the winter peak, with weekly rates falling below 2 per 100,000 by March and forecasts showing continued low admissions through mid-June amid typical seasonal patterns of reduced transmission in warmer months. This positioning aligns with historical late-spring data where cumulative totals plateau without major new surges. A late unexpected variant-driven increase or significant upward data revisions could shift outcomes outside this narrow band, though current surveillance indicates low likelihood before resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Tasa de hospitalización por gripe en la semana 21 de 2026?
¿Tasa de hospitalización por gripe en la semana 21 de 2026?
85–90 97.5%
<80 1.7%
80–85 1.1%
90–95 <1%
NUEVO
NUEVO
5 jun 2026
<80
2%
80–85
1%
85–90
98%
90–95
1%
95–100
<1%
100 o más
1%
85–90 97.5%
<80 1.7%
80–85 1.1%
90–95 <1%
NUEVO
NUEVO
5 jun 2026
<80
$561 Vol.
2%
80–85
$268 Vol.
1%
85–90
$915 Vol.
98%
90–95
$1,192 Vol.
1%
95–100
$840 Vol.
<1%
100 o más
$883 Vol.
1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant 97.5% market-implied probability on an 85–90 flu hospitalization rate for Week 21, 2026, reflects the expected stabilization of cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET as the 2025–2026 season concludes. Activity has declined sharply since the winter peak, with weekly rates falling below 2 per 100,000 by March and forecasts showing continued low admissions through mid-June amid typical seasonal patterns of reduced transmission in warmer months. This positioning aligns with historical late-spring data where cumulative totals plateau without major new surges. A late unexpected variant-driven increase or significant upward data revisions could shift outcomes outside this narrow band, though current surveillance indicates low likelihood before resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercado abierto: Jun 1, 2026, 12:42 PM ET
Volumen
$4,659Fecha de finalización
5 jun 2026Mercado abierto
Jun 1, 2026, 12:42 PM ETFuente de resolución
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant 97.5% market-implied probability on an 85–90 flu hospitalization rate for Week 21, 2026, reflects the expected stabilization of cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET as the 2025–2026 season concludes. Activity has declined sharply since the winter peak, with weekly rates falling below 2 per 100,000 by March and forecasts showing continued low admissions through mid-June amid typical seasonal patterns of reduced transmission in warmer months. This positioning aligns with historical late-spring data where cumulative totals plateau without major new surges. A late unexpected variant-driven increase or significant upward data revisions could shift outcomes outside this narrow band, though current surveillance indicates low likelihood before resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$4,659Fecha de finalización
5 jun 2026Mercado abierto
Jun 1, 2026, 12:42 PM ETFuente de resolución
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...The dominant 97.5% market-implied probability on an 85–90 flu hospitalization rate for Week 21, 2026, reflects the expected stabilization of cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET as the 2025–2026 season concludes. Activity has declined sharply since the winter peak, with weekly rates falling below 2 per 100,000 by March and forecasts showing continued low admissions through mid-June amid typical seasonal patterns of reduced transmission in warmer months. This positioning aligns with historical late-spring data where cumulative totals plateau without major new surges. A late unexpected variant-driven increase or significant upward data revisions could shift outcomes outside this narrow band, though current surveillance indicates low likelihood before resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes